Scott Henry
Stock Analyst at Alliance Global Partners
(1.72)
# 3,096
Out of 4,732 analysts
59
Total ratings
39.22%
Success rate
-2.39%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $5.74 | +4.53% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $4.37 | +128.83% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.83 | +232.41% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $3.66 | +132.24% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.50 | +166.67% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.87 | +702.14% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $1.77 | +577.97% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $9.78 | -23.31% | 2 | Sep 22, 2023 | |
| DCTH Delcath Systems | Maintains: Buy | $10 → $13 | $14.31 | -9.15% | 4 | Aug 16, 2023 | |
| VKTX Viking Therapeutics | Maintains: Buy | $19 → $24 | $32.65 | -26.49% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $111.89 | -19.56% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $22.78 | -31.96% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $99.06 | -41.45% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $59.17 | -39.16% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.66 | +562.65% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $6.56 | -8.54% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $4.95 | +116,061.62% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.19 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $6.10 | +14.75% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.24 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.73 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.84 | - | 1 | Nov 10, 2017 |
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $5.74
Upside: +4.53%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $4.37
Upside: +128.83%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.83
Upside: +232.41%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $3.66
Upside: +132.24%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.50
Upside: +166.67%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.87
Upside: +702.14%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $1.77
Upside: +577.97%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $9.78
Upside: -23.31%
Delcath Systems
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $14.31
Upside: -9.15%
Viking Therapeutics
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $32.65
Upside: -26.49%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $111.89
Upside: -19.56%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $22.78
Upside: -31.96%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $99.06
Upside: -41.45%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $59.17
Upside: -39.16%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.66
Upside: +562.65%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $6.56
Upside: -8.54%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $4.95
Upside: +116,061.62%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.19
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $6.10
Upside: +14.75%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $0.24
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.73
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.84
Upside: -